Globus Medical (NYSE:GMED) and Disaboom (OTCMKTS:MEDH) Head to Head Contrast

Disaboom (OTCMKTS:MEDH) and Globus Medical (NYSE:GMED) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings.

Earnings and Valuation

This table compares Disaboom and Globus Medical”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Disaboom	$890,000.00	0.85	-$170,000.00	N/A	N/A
Globus Medical	$2.52 billion	3.08	$102.98 million	$2.60	22.13

Globus Medical has higher revenue and earnings than Disaboom.

Institutional and Insider Ownership

95.2% of Globus Medical shares are held by institutional investors. 18.5% of Globus Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Disaboom and Globus Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Disaboom	0	0	0	0	0.00
Globus Medical	0	6	8	0	2.57

Globus Medical has a consensus price target of $87.27, suggesting a potential upside of 51.70%. Given Globus Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Globus Medical is more favorable than Disaboom.

Risk and Volatility

Disaboom has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500. Comparatively, Globus Medical has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500.

Profitability

This table compares Disaboom and Globus Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Disaboom	-3.05%	N/A	N/A
Globus Medical	13.58%	10.65%	8.86%

Summary

Globus Medical beats Disaboom on 12 of the 12 factors compared between the two stocks.

About Disaboom

Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming.

About Globus Medical

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.